News Janssen drug approved in combination against myeloma FDA backs Darzalex in multiple myeloma second line.
News Janssen licenses drugs to artificial intelligence company BenevolentAI's Judgment Augmented Cognition System will help develop the new drugs.
News Janssen’s depression drug gains second breakthrough status Drug could help prevent some of the 41,000 suicides every year in US
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
